The molecular typing of breast cancer is based on immunohistochemical indicators estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index (Ki-67). Here, PGR is linked to breast carcinoma.